Ontogeny of oral drug absorption processes in children

Expert Opinion on Drug Metabolism and Toxicology

Volumn 8, Issue 10, 2012, Pages 1293-1303

  Mooij, Miriam G ^a   De Koning, Barbara Ae ^a   Huijsman, Mark L ^a   De Wildt, Saskia N ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Absorption; Administration; Child; Oral; Pharmaceutical preparations

Indexed keywords

BILE SALT; CARRIER PROTEIN; CYCLOSPORIN; ENZYME; INTESTINAL DRUG METABOLIZING ENZYME; MIDAZOLAM; PARACETAMOL; UNCLASSIFIED DRUG;

ANTRODUODENAL CONTRACTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; GASTROINTESTINAL MOTILITY; HUMAN; INTESTINE PH; INTESTINE TRANSIT TIME; MAXIMUM PLASMA CONCENTRATION; ONTOGENY; ORAL DRUG ADMINISTRATION; OROCECAL TRANSIT TIME; PANCREAS FUNCTION; PH; REVIEW; STOMACH EMPTYING; STOMACH PH; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; BILE ACIDS AND SALTS; BIOLOGICAL AVAILABILITY; CARRIER PROTEINS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; INTESTINES; PANCREAS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

EID: 84866504198     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2012.698261     Document Type: Review

References (101)

1. Schirm E, Tobi H, de Vries TW, et al. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr 2003;92(12):1486-9 (Pubitemid 38114502)
2. Atkinson AJ, Abernethy DR, Daniels CE, et al. Drug absorption and bioavailability. In: Principles of clinical pharmacology. 2nd edition. Academic Press; Burlington USA; 2007. p 37-58
3. Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals. J Clin Pharmacol 2002;42(6):620-43 (Pubitemid 34547446)
4. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349(12):1157-67 (Pubitemid 37122329)
5. Jacqz-Aigrain E. Drug policy in Europe Research and funding in neonates: Current challenges, future perspectives, new opportunities. Early Hum Dev 2011;87(Suppl 1):S27-30
6. FDA. U.S. Food and Drug Administration. Available from: Http://www.fda.gov/Science Research/SpecialTopics/PediatricTherapeuticsResearch/ default.htm
7. Hines RN, McCarver DG. The ontogeny of human drug-metabolizing enzymes: Phase I oxidative enzymes. J Pharmacol Exp Ther 2002;300(2):355-60 (Pubitemid 34106223)
8. Smits A, Kulo A, de Hoon JN, Allegaert K. Pharmacokinetics of drugs in neonates: Pattern recognition beyond compound specific observations. Curr Pharm Des 2012. [Epub ahead of print]
9. Strolin Benedetti M, Whomsley R, Baltes EL. Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations. Expert Opin Drug Metab Toxicol 2005;1(3):447-71
10. Yokoi T. Essentials for starting a pediatric clinical study (1): Pharmacokinetics in children. J Toxicol Sci 2009;34(Suppl 2): SP307-12
11. Bowles A, Keane J, Ernest T, et al. Specific aspects of gastro-intestinal transit in children for drug delivery design. Int J Pharm 2010;395(1-2):37-43
12. Datta S, Houle GL, Fox GS. Concentration of lidocaine hydrochloride in newborn gastric fluid after elective caesarean section and vaginal delivery with epidural analgesia. Can Anaesth Soc J 1975;22(1):79-83
13. Whetstine LJ, Hulsey TC, Annibale DJ, Pittard WB. Supplemental oxygen and gastric pH in unfed preterm infants. South Med J 1995;88(4):458-61
14. Miller RA. Observations on the gastric acidity during the first month of life. Arch Dis Child 1941;16(85):22-30
15. Cote CJ, Goudsouzian NG, Liu LM, et al. Assessment of risk factors related to the acid aspiration syndrome in pediatric patients-gastric ph and residual volume. Anesthesiology 1982;56(1):70-2 (Pubitemid 12204776)
16. Goresky GV, Finley GA, Bissonnette B, Shaffer EA. Efficacy, duration, and absorption of a paediatric oral liquid preparation of ranitidine hydrochloride. Can J Anaesth 1992;39(8):791-8
17. Jahr JS, Burckart G, Smith SS, et al. Effects of famotidine on gastric pH and residual volume in pediatric surgery. Acta Anaesthesiol Scand 1991;35(5):457-60
18. Kelly EJ, Chatfield SL, Brownlee KG, et al. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone. Arch Dis Child 1993;69(1 Spec No):37-9 (Pubitemid 23232979)
19. Kelly EJ, Newell SJ, Brownlee KG, et al. Gastric acid secretion in preterm infants. Early Hum Dev 1993;35(3):215-20 (Pubitemid 24053222)
20. Kraus G, Krishna DR, Chmelarsch D, et al. Famotidine. Pharmacokinetic properties and suppression of acid secretion in paediatric patients following cardiac surgery. Clin Pharmacokinet 1990;18(1):77-81
21. Maekawa N, Mikawa K, Yaku H, et al. Effects of 2-, 4- and 12-h fasting intervals on preoperative gastric fluid pH and volume, and plasma glucose and lipid homeostasis in children. Acta Anaesthesiol Scand 1993;37(8):783-7
22. Miller BR, Tharp JA, Issacs WB. Gastric residual volume in infants and children following a 3-h fast. J Clin Anesth 1990;2(5):301-5 (Pubitemid 20326170)
23. Nishina K, Mikawa K, Maekawa N, et al. Omeprazole reduces preoperative gastric fluid acidity and volume in children. Can J Anaesth 1994;41(10):925-9 (Pubitemid 24356867)
24. Oderda G, Rapa A, Chiorboli E, et al. Measurement of postprandial changes in urine acid output to detect changes of gastric acid secretion after proton pump inhibitors in children. Dig Dis Sci 2002;47(8):1843-9 (Pubitemid 34833218)
25. Omari TI, Davidson GP. Multipoint measurement of intragastric pH in healthy preterm infants. Arch Dis Child Fetal Neonatal Ed 2003;88(6):F517-20 (Pubitemid 37449429)
26. Rogers IM, Drainer IK, Moore MR, Buchanan KD. Plasma gastrin in congenitial hypertrophic pyloric stenosis. A hypothesis disproved. Arch Dis Child 1975;50(6):467-71
27. Smith LJ, Kaminsky S, D'Souza SW. Neonatal fat digestion and lingual lipase. Acta Paediatr Scand 1986;75(6):913-18 (Pubitemid 17185102)
28. Splinter WM, Schaefer JD. Unlimited clear fluid ingestion two hours before surgery in children does not affect volume or pH of stomach contents. Anaesth Intensive Care 1990;18(4):522-6 (Pubitemid 20365292)
29. Splinter WM, Stewart JA, Muir JG. Large volumes of apple juice preoperatively do not affect gastric pH and volume in children. Can J Anaesth 1990;37(1):36-9 (Pubitemid 20029297)
30. Yildiz F, Tryba M, Kuehn K, Hausdoerfer J. Reduction of gastric acid secretion. The efficacy of pre-anaesthetic oral cimetidine in children. Anaesthesia 1984;39(4):314-18 (Pubitemid 15118359)
31. Lopez-Alonso M, Moya MJ, Cabo JA, et al. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: Rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. Pediatrics 2006;118(2):e299-308 (Pubitemid 46090505)
32. Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr 2007;44(1):41-4 (Pubitemid 46071790)
33. Demir H, Ozen H, Kocak N, et al. Does simultaneous gastric and esophageal pH monitoring increase the diagnosis of gastroesophageal reflux disease? Turk J Pediatr 2005;47(1):14-16 (Pubitemid 40590396)
34. Kleinman RE, Goulet OJ, Mieli-Vergani G, et al. Walker's pediatric gastrointestinal disease. People's Medical Publishing House; Shelton, CT: 2008
35. Boyle JT. Acid secretion from birth to adulthood. J Pediatr Gastroenterol Nutr 2003;37(Suppl 1):S12-16
36. Huang NN, High RH. Comparison of serum levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groups. J Pediatr 1953;42(6):657-8
37. Hoekstra JH, van den Aker JH, Kneepkens CM, et al. Evaluation of 13CO2 breath tests for the detection of fructose malabsorption. J Lab Clin Med 1996;127(3):303-9 (Pubitemid 126657311)
38. Perri F, Pastore M, Zicolella A, et al. Gastric emptying of solids is delayed in celiac disease and normalizes after gluten withdrawal. Acta Paediatr 2000;89(8):921-5 (Pubitemid 30643724)
39. Hoffman I, Tertychnyy A, Ectors N, et al. Duodenogastro-esophageal reflux in children with refractory gastro-esophageal reflux disease. J Pediatr 2007;151(3):307-11 (Pubitemid 47284129)
40. Bode S, Dreyer M, Greisen G. Gastric emptying and small intestinal transit time in preterm infants: A scintigraphic method. J Pediatr Gastroenterol Nutr 2004;39(4):378-82
41. Di Lorenzo C, Piepsz A, Ham H, Cadranel S. Gastric emptying with gastro-oesophageal reflux. Arch Dis Child 1987;62(5):449-53
42. Seibert JJ, Byrne WJ, Euler AR. Gastric emptying in children: Unusual patterns detected by scintigraphy. AJR Am J Roentgenol 1983;141(1):49-51 (Pubitemid 13063876)
43. Cucchiara S, Bortolotti M, Colombo C, et al. Abnormalities of gastrointestinal motility in children with nonulcer dyspepsia and in children with gastroesophageal reflux disease. Dig Dis Sci 1991;36(8):1066-73
44. Miele E, Tozzi A, Staiano A, et al. Persistence of abnormal gastrointestinal motility after operation for Hirschsprung's disease. Am J Gastroenterol 2000;95(5):1226-30 (Pubitemid 30263517)
45. Yahav J, Avigad S, Frand M, et al. Assessment of intestinal and cardiorespiratory function in children with congenital heart disease on high-caloric formulas. J Pediatr Gastroenterol Nutr 1985;4(5):778-85 (Pubitemid 15048893)
46. Demirbilek S, Karaman A, Gurunluoglu K, et al. Delayed gastric emptying in gastroesophageal reflux disease: The role of malrotation. Pediatr Surg Int 2005;21(6):423-7 (Pubitemid 40922371)
47. Graff J, Brinch K, Madsen JL. Simplified scintigraphic methods for measuring gastrointestinal transit times. Clin Physiol 2000;20(4):262-6 (Pubitemid 30456123)
48. Bennink R, Peeters M, Van den Maegdenbergh V, et al. Evaluation of small-bowel transit for solid and liquid test meal in healthy men and women. Eur J Nucl Med 1999;26(12):1560-6 (Pubitemid 30010293)
49. Mayer AP, Durward A, Turner C, et al. Amylin is associated with delayed gastric emptying in critically ill children. Intensive Care Med 2002;28(3):336-40 (Pubitemid 34230657)
50. Lodefalk M, Aman J, Bang P. Effects of fat supplementation on glycaemic response and gastric emptying in adolescents with type 1 diabetes. Diabet Med 2008;25(9):1030-5
51. Anderson BJ, van Lingen RA, Hansen TG, et al. Acetaminophen developmental pharmacokinetics in premature neonates and infants: A pooled population analysis. Anesthesiology 2002;96(6):1336-45 (Pubitemid 34587201)
52. Berseth CL, Ittmann PI. Antral and duodenal motor responses to duodenal feeding in preterm and term infants. J Pediatr Gastroenterol Nutr 1992;14(2):182-6
53. Ittmann PI, Amarnath R, Berseth CL. Maturation of antroduodenal motor activity in preterm and term infants. Dig Dis Sci 1992;37(1):14-19
54. Morriss FH Jr, Moore M, Weisbrodt NW, West MS. Ontogenic development of gastrointestinal motility: IV. Duodenal contractions in preterm infants. Pediatrics 1986;78(6):1106-13 (Pubitemid 17190255)
55. Bisset WM, Watt JB, Rivers RP, Milla PJ. Measurement of small-intestinal motor activity in the preterm infant. J Biomed Eng 1988;10(2):155-8 (Pubitemid 18092868)
56. Berseth CL, Nordyke CK, Valdes MG, et al. Responses of gastrointestinal peptides and motor activity to milk and water feedings in preterm and term infants. Pediatr Res 1992;31(6):587-90
57. Al Tawil Y, Berseth CL. Gestational and postnatal maturation of duodenal motor responses to intragastric feeding. J Pediatr 1996;129(3):374-81 (Pubitemid 27484143)
58. Vajro P, Silano G, Longo D, et al. Orocoecal transit time in healthy and constipated children. Acta Paediatr Scand 1988;77(4):583-6
59. Van Den Driessche M, Van Malderen N, Geypens B, et al. Lactose-[13C]ureide breath test: A new, noninvasive technique to determine orocecal transit time in children. J Pediatr Gastroenterol Nutr 2000;31(4):433-8
60. Khin M, Bolin TD, Tin O, et al. Investigation of small-intestinal transit time in normal and malnourished children. J Gastroenterol 1999;34(6):675-9
61. Murphy MS, Nelson R, Eastham EJ. Measurement of small intestinal transit time in children. Acta Paediatr Scand 1988;77(6):802-6 (Pubitemid 19008607)
62. Vreugdenhil G, Sinaasappel M, Bouquet J. A comparative study of the mouth to caecum transit time in children and adults using a weight adapted lactulose dose. Acta Paediatr Scand 1986;75(3):483-8 (Pubitemid 16064156)
63. Geypens B, Bennink R, Peeters M, et al. Validation of the lactose-[13C]ureide breath test for determination of orocecal transit time by scintigraphy. J Nucl Med 1999;40(9):1451-5 (Pubitemid 29428926)
64. Wutzke KD, Heine WE, Plath C, et al. Evaluation of oro-coecal transit time: A comparison of the lactose-[13C, 15N] ureide 13CO2- and the lactulose H2-breath test in humans. Eur J Clin Nutr 1997;51(1):11-19 (Pubitemid 27055533)
65. Fallingborg J, Christensen LA, Ingeman-Nielsen M, et al. Measurement of gastrointestinal pH and regional transit times in normal children. J Pediatr Gastroenterol Nutr 1990;11(2):211-14 (Pubitemid 20225906)
66. Boehm G, Bierbach U, Senger H, et al. Activities of lipase and trypsin in duodenal juice of infants small for gestational age. J Pediatr Gastroenterol Nutr 1991;12(3):324-7
67. Jarvenpaa AL, Rassin DK, Kuitunen P, et al. Feeding the low-birth-weight infant. III. Diet influences bile acid metabolism. Pediatrics 1983;72(5):677-83 (Pubitemid 14232889)
68. Challacombe DN, Edkins S, Brown GA. Duodenal bile acids in infancy. Arch Dis Child 1975;50(11):837-43
69. Walkowiak J, Herzig KH, Strzykala K, et al. Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 2002;110(1 Pt 1):e7
70. Nissler K, Von Katte I, Huebner A, Henker J. Pancreatic elastase 1 in feces of preterm and term infants. J Pediatr Gastroenterol Nutr 2001;33(1):28-31 (Pubitemid 32706120)
71. de Winter BC, Monchaud C, Premaud A, et al. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients. Clin Pharmacokinet 2012;51(1):29-39
72. Hines RN. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 2008;118(2):250-67
73. Stevens JC, Hines RN, Gu C, et al. Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 2003;307(2):573-82
74. Fakhoury M, Litalien C, Medard Y, et al. Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age. Drug Metab Dispos 2005;33(11):1603-7 (Pubitemid 41539956)
75. Johnson TN, Tanner MS, Taylor CJ, Tucker GT. Enterocytic CYP3A4 in a paediatric population: Developmental changes and the effect of coeliac disease and cystic fibrosis. Br J Clin Pharmacol 2001;51(5):451-60
76. Treluyer JM, Jacqz-Aigrain E, Alvarez F, Cresteil T. Expression of CYP2D6 in developing human liver. Eur J Biochem 1991;202(2):583-8
77. Fukudo M, Yano I, Masuda S, et al. Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients. Clin Pharmacol Ther 2006;80(4):331-45 (Pubitemid 44479749)
78. Fukudo M, Yano I, Yoshimura A, et al. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Pharmacogenet Genomics 2008;18(5):413-23 (Pubitemid 351535942)
79. De Wildt SN, Kearns GL, Hop WC, et al. Pharmacokinetics and metabolism of oral midazolam in preterm infants. Br J Clin Pharmacol 2002;53(4):390-2 (Pubitemid 34415590)
80. Paine MF, Shen DD, Kunze KL, et al. First-pass metabolism of midazolam by the human intestine. Clin Pharmacol Ther 1996;60(1):14-24 (Pubitemid 26279216)
81. Mandema JW, Tuk B, van Steveninck AL, et al. Pharmacokinetic- pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther 1992;51(6):715-28
82. Blake MJ, Abdel-Rahman SM, Pearce RE, et al. Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants. Pediatr Res 2006;60(6):717-23 (Pubitemid 44789515)
83. Dietrich CG, Geier A, Oude Elferink RP. ABC of oral bioavailability: Transporters as gatekeepers in the gut. Gut 2003;52(12):1788-95 (Pubitemid 37510405)
84. Cascorbi I. P-glycoprotein: Tissue distribution, substrates, and functional consequences of genetic variations. Handb Exp Pharmacol 2011;201:261-83
85. Fanta S, Niemi M, Jonsson S, et al. Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms. Pharmacogenet Genomics 2008;18(2):77-90
86. Fakhoury M, Lecordier J, Medard Y, et al. Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn's disease. Inflamm Bowel Dis 2006;12(8):745-9 (Pubitemid 44253759)
87. Zhao W, Fakhoury M, Deschenes G, et al. Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients. J Clin Pharmacol 2010;50(11):1280-91
88. Ohmann EL, Burckart GJ, Brooks MM, et al. Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients. J Heart Lung Transplant 2010;29(5):509-16
89. Zhao W, Elie V, Roussey G, et al. Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients. Clin Pharmacol Ther 2009;86(6):609-18
90. Blanquet S, Zeijdner E, Beyssac E, et al. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm Res 2004;21(4):585-91 (Pubitemid 38457280)
91. Brouwers J, Anneveld B, Goudappel GJ, et al. Food-dependent disintegration of immediate release fosamprenavir tablets: In vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system. Eur J Pharm Biopharm 2011;77(2):313-19
92. Wilding IR, Kenyon CJ, Hooper G. Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet. Aliment Pharmacol Ther 2000;14(2):163-9 (Pubitemid 30088292)
93. Hines RN. Ontogeny of human hepatic cytochromes P450. J Biochem Mol Toxicol 2007;21(4):169-75 (Pubitemid 350194376)
94. Johnson TN, Rostami-Hodjegan A, Tucker GT. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clin Pharmacokinet 2006;45(9):931-56 (Pubitemid 44299829)
95. Ince I, de Wildt SN, Tibboel D, et al. Tailor-made drug treatment for children: Creation of an infrastructure for data-sharing and population PK-PD modeling. Drug Discov Today 2009;14(5-6):316-20
96. de Wildt SN, Ito S, Koren G. Challenges for drug studies in children: CYP3A phenotyping as example. Drug Discov Today 2009;14(1-2):6-15
97. Gorski JC, Jones DR, Haehner-Daniels BD, et al. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Clin Pharmacol Ther 1998;64(2):133-43 (Pubitemid 28423848)
98. Lappin G, Shishikura Y, Jochemsen R, et al. Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers. Eur J Pharm Sci 2011;43(3):141-50
99. Lappin G, Garner RC. The utility of microdosing over the past 5 years. Expert Opin Drug Metab Toxicol 2008;4(12):1499-506
100. Lappin G, Kuhnz W, Jochemsen R, et al. Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs. Clin Pharmacol Ther 2006;80(3):203-15 (Pubitemid 44313903)
101. Baillie R, Gordi T, Vuong L, et al. Evaluation of Ursodiol Pharmacokinetics in Neonates Using AMS, 2011; Available from: Http://www.rosaandco.com/posters/rosaVitaleaASCPTposter2011.pdf. February 2012